Salahadin Abdi, MD, PhD
Department of Pain Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
Salahadin Abdi, MD, PhD, is a tenured Professor of Anesthesiology/Pain Medicine and Chair, Department of Pain Medicine at University of Texas MD Anderson Cancer Center in Houston, TX. Prior to his current appointment, Dr. Abdi was Chief of Division of Pain Medicine at Beth Israel Deaconess Medical Center, Harvard Medical School in Boston, Professor and Chief of Pain Medicine at the University of Miami, LM Miller School of Medicine, Miami, FL and the Director of MGH Pain Center at the Massachusetts General Hospital, Harvard Medical School in Boston.
Dr. Abdi is board certified in Anesthesiology and Pain Medicine. He is an active member in various national and international medical societies including ASA, ASRA, APS, ISMISS, SfN, ASIPP, etc. Dr. Abdi is editor and/or associate editor of several national and international journals such as Pain Physician, Annals of Palliative Medicine, Korean Journal of Pain, Frontiers in Pain Pharmacol & Therap, Frontiers in Psychiatry, Frontiers in Neuroscience, Lasers in Med Science, World Journal of Anesthesiology to name a few; and member of board of directors of American Society of Interventional Pain Physicians. Dr. Abdi has attended many National and International meetings as an invited Speaker and also served as a Visiting Professor in national and international institutes worldwide. Dr. Abdi co-edited three books and currently working on two additional books. Furthermore, he has authored and/or co-authored more than 200 manuscripts and abstracts, book chapters and review articles. He is a reviewer for journals such as: Spine, Current Opinion in Anesthesiology, Anesthesiology, Emerging Drugs, Pain Physician, Pain Medicine, Clinical Journal of Pain, American journal of geriatric pharmacology, World Scientific Journal, Frontiers in Psychiatry, Pharmacology & therapeutics, Lasers in Med Science, to name a few. Dr. Abdi’s primary research interests include stem cell and gene therapy for degenerative spine disease and chemotherapy induced painful peripheral neuropathy. His main clinical interest includes low back pain, complex regional pain syndrome, cancer pain, myofascial pain and whiplash injury.